2002 Fiscal Year Final Research Report Summary
Research on the payment system for preventing drug duplication and interaction under the separation of prescribing and dispensing
| Project/Area Number |
13670355
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Public health/Health science
|
|---|
| Research Institution | The Univesity of Tokyo |
|---|
Principal Investigator |
KOBAYASHI Yasuki The University of Tokyo, Graduate School of Medicine, Professor, 大学院・医学系研究科, 教授 (70178341)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
FUKUDA Takashi The University of Tokyo, Graduate School of Pharmacy, Associate Professor, 大学院・薬学系研究科, 助教授 (40272421)
|
|---|
| Project Period (FY) |
2001 – 2002
|
| Keywords | separation of prescribing and dispensing / pharmaceuticals / drug interaction / drug duplication / health insurance / pharmacy / payment system |
|---|
| Research Abstract |
We examined the present situation wherein pharmacies claimed the fees for preventing adverse duplications and/or interactions of prescription drugs, in order to consider the more relevant and effective payment system in Japan's health insurance systems. All of the pharmacies registered as "insurance pharmacy" by the Tokyo Metropolitan Government in April 1999 were surveyed in this regard. Out of 4,854 pharmacies, 1,506 (31.0%) responded. Of all of the prescriptions received by these pharmacies, the proportion of prescriptions claiming the fee was 0.0088%. This proportion was not significantly different between "Monzen Yakkyoku" pharmacies that received more than 70% of prescriptions from a particular medical institution, and the rest pharmacies. Other characteristics of pharmacies, such as number of pharmacists, size of the pharmacy, years of operation, being registered as a standard pharmacy by the Tokyo Metropolitan Government or not, were not significantly related to the proportion. We added an interview survey on some pharmacists, and found that the current payment system was inflexible in terms of claiming such fees. We also found, by another study, that more than 40% of the patients concurrently visited two medical institutions or more : Therefore, the issue of preventing adverse duplications and/or interactions of those drugs prescribed by different physicians/institutions is very important in terms of reforming the payment system.
|
Research Products
(2 results)
